Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6775 (miR-6775) is a member of the microRNA family, a class of small non-coding RNAs broadly conserved in animals and functioning primarily as post-transcriptional regulators of gene expression. miR-6775 is transcribed as a precursor that is processed to form mature miRNA strands (e.g., miR-6775-3p, miR-6775-5p). In recent research, elevated miR-6775-3p expression correlates with improved prognosis in esophageal squamous cell carcinoma, and experimental overexpression inhibits tumor growth and metastasis in mouse xenograft models. p53 upregulates both miR-6775-3p and the solute carrier transporter SLC7A5; miR-6775-3p in turn downregulates SLC7A5 and members of the MAGE-A family, which are associated with tumor progression. As with other miRNAs, miR-6775 is not an enzyme, receptor, or transporter, but rather a post-transcriptional gene regulator classified as a non-coding RNA. The role of miR-6775 in cancer suppression and regulation of cell proliferation is experimentally documented, but evidence for involvement in other disease areas and therapeutic targeting is currently limited.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6775 (miR-6775).